Clinical Trials Browser

Phase 2 × Lung Neoplasms × Adjuvants, Pharmaceutic × Clear all

NCT06788912 2026-03-10

MK-3475-01E

Phase 2 Recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lung Neoplasms